Screener
LivaNova LIVN Cardiopulmonary — Goodwill
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by LivaNova in its filing.
Tagged under the XBRL concept us-gaap:Goodwill.
The source filing: LivaNova’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 2:23 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001639691-26-000090
FAQ
- What is LivaNova's cardiopulmonary — goodwill?
- LivaNova (LIVN) reported cardiopulmonary — goodwill of $380.39M in Q2 2026.
- How has LivaNova's cardiopulmonary — goodwill changed year-over-year?
- LivaNova's cardiopulmonary — goodwill decreased by 3.6% year-over-year, from $394.61M to $380.39M.
- What is the long-term trend for LivaNova's cardiopulmonary — goodwill?
- Over 3 years (2022 to 2025), LivaNova's cardiopulmonary — goodwill has grown at a 1.4% compound annual growth rate (CAGR), from $1.48B to $1.54B.
- What does cardiopulmonary — goodwill mean?
- Represents the intangible asset value recognized when the cardiopulmonary segment acquires another business for a price exceeding the fair market value of its net identifiable assets. It serves as a measure of the premium paid for expected future synergies and brand value.
Ask your AI about LivaNova's cardiopulmonary — goodwill.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude